Drug recall · December 15, 2021
Fexofenadine HCl recall
Why: Failed dissolution specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fexofenadine HCl, 60 mg & Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy and Congestion, 30 Tablets, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ, 08640, Made in India NDC Walmart Inc., Bentonville, AR 72716, Product of India, NDC 43598-823-31.
- Lots / codes
Lot #: AC2103329A
- Quantity
- 2,928 cartons
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- USA Nationwide.
- Initiated
- November 12, 2021 · N/A
- Classified
- December 7, 2021
- Reported
- December 15, 2021
- Ended
- June 23, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine / pseudoephedrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.